We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,725 hedge funds and large institutions have $233B invested in Johnson & Johnson in 2019 Q3 according to their latest regulatory filings, with 91 funds opening new positions, 1,041 increasing their positions, 1,352 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% less funds holding

Funds holding: 2,7562,725 (-31)

4.6% less ownership

Funds ownership: 72.98%68.38% (-4.6%)

7% less capital invested

Capital invested by funds: $252B → $233B (-$18.5B)

11% less call options, than puts

Call options by funds: $1.71B | Put options by funds: $1.91B

11% less first-time investments, than exits

New positions opened: 91 | Existing positions closed: 102

23% less repeat investments, than reductions

Existing positions increased: 1,041 | Existing positions reduced: 1,352

24% less funds holding in top 10

Funds holding in top 10: 639485 (-154)

Holders
2,725
Holders Change
-31
Holders Change %
-1.12%
% of All Funds
59.75%
Holding in Top 10
485
Holding in Top 10 Change
-154
Holding in Top 10 Change %
-24.1%
% of All Funds
10.63%
New
91
Increased
1,041
Reduced
1,352
Closed
102
Calls
$1.71B
Puts
$1.91B
Net Calls
-$203M
Net Calls Change
+$4.99M
Name Holding Trade Value Shares
Change
Change in
Stake
FAF
1226
Första AP-fonden
Sweden
$4.25M -$11.7M -89,100 -73%
PC
1227
Pecaut & Co
Iowa
$4.24M -$608K -4,615 -12%
Loomis, Sayles & Company
1228
Loomis, Sayles & Company
Massachusetts
$4.24M -$35.2K -267 -0.8%
OC
1229
Oarsman Capital
Wisconsin
$4.23M +$70.2K +533 +2%
TW
1230
Transform Wealth
Colorado
$4.22M -$506K -3,838 -11%
SCA
1231
Spearhead Capital Advisors
Florida
$4.22M +$307K +2,333 +8%
Cetera Investment Advisers
1232
Cetera Investment Advisers
Illinois
$4.22M -$154K -1,166 -3%
EWM
1233
Executive Wealth Management
Michigan
$4.2M +$520K +3,947 +14%
CCM
1234
Consolidated Capital Management
California
$4.19M -$315K -2,389 -7%
BCM
1235
Brookstone Capital Management
Illinois
$4.19M -$761K -5,778 -15%
PL
1236
Parkwood LLC
Ohio
$4.18M +$224K +1,697 +6%
AM
1237
Atwater Malick
Pennsylvania
$4.18M +$109K +831 +3%
SFG
1238
SevenBridge Financial Group
Pennsylvania
$4.17M -$514K -3,903 -11%
AAF
1239
Andra AP-fonden
Sweden
$4.17M -$487K -3,700 -10%
NDSI
1240
Newman Dignan & Sheerar Inc
Rhode Island
$4.16M -$138K -1,047 -3%
CG
1241
Caprock Group
Idaho
$4.16M -$185K -1,403 -4%
MSA
1242
Marino Stram & Associates
Massachusetts
$4.15M -$16.9K -128 -0.4%
ABP
1243
Arthur B. Page
$4.15M -$71.1K -540 -2%
MAM
1244
Morse Asset Management
Connecticut
$4.13M -$1.3M -9,840 -24%
BMA
1245
Brooks Moore & Associates
Tennessee
$4.13M +$102K +771 +2%
PA
1246
Parallel Advisors
California
$4.13M +$384K +2,911 +10%
PWMAG
1247
Pinnacle Wealth Management Advisory Group
New Jersey
$4.13M -$30.2K -229 -0.7%
SCM
1248
Shelton Capital Management
Colorado
$4.13M -$92.2K -700 -2%
FFA
1249
Fragasso Financial Advisors
Pennsylvania
$4.12M +$71.7K +544 +2%
BWM
1250
BerganKDV Wealth Management
Minnesota
$4.11M +$193K +1,468 +5%

JNJ Hedge Fund Activity: Q3 2019 in Review

2,725 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q3 2019, worth a combined $233B — down 7.4% from $252B a quarter earlier.

Sellers outnumbered buyers: 102 funds closed out of JNJ and 91 opened new positions — a net loss of 11 holders — while 1,352 trimmed existing stakes and 1,041 added.

The largest buyer was Wellington Management Group, adding an estimated $304M. The largest seller was Phocas Financial Corp, cutting an estimated $16.5B.

  • 2,725 institutional investors held Johnson & Johnson (JNJ) as of Q3 2019, down from 2,756 in Q2 2019.
  • Funds reported $233B of Johnson & Johnson stock for Q3 2019, down 7.4% quarter-over-quarter.
  • 91 funds opened new Johnson & Johnson positions in Q3 2019 and 102 closed out, a net change of -11 holders.
  • The largest Johnson & Johnson buyer in Q3 2019 was Wellington Management Group, an estimated $304M added.
  • The largest Johnson & Johnson seller in Q3 2019 was Phocas Financial Corp, an estimated $16.5B sold.

Based on aggregated 13F filings for Q3 2019.